Where is the hope for drug discovery? Let history tell the future

被引:111
作者
Kong, De-Xin [1 ]
Li, Xue-Juan [1 ]
Zhang, Hong-Yu [1 ]
机构
[1] Shandong Univ Technol, Ctr Adv Study, Shandong Prov Res Ctr Bioinformat Engn & Tech, Zibo 255049, Peoples R China
关键词
TRADITIONAL CHINESE MEDICINE; COMBAT ALZHEIMERS-DISEASE; COMBINATION-DRUGS; WESTERN-MEDICINE; NATURAL-PRODUCTS; ARSENIC UPTAKE; HUPERZINE-A; NETWORK; TARGET; THERAPY;
D O I
10.1016/j.drudis.2008.07.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For drug discovery, historical experience is always of significance. Through examining the history of traditional medicines, we find that these medicines have more implications for drug discovery than just providing new chemical entities. The history of traditional medicines indicates that they depended more on the combination of natural agents than on screening new agents to find new remedies. This phenomenon suggests that shifting the current drug discovery paradigm from 'finding new-entity drugs' to 'combining existing agents' may be helpful for overcoming the 'more investment, fewer drugs' challenge. We show that clues to finding antidementia combinatorial drugs can be derived from traditional medicine formulae. It seems that to create a brighter future of drug discovery, we would better go back to history.
引用
收藏
页码:115 / 119
页数:5
相关论文
共 59 条
  • [1] [Anonymous], 2005, USE COMPLEMENTARY AL
  • [2] [Anonymous], 1995, CHIN J HEMATOL
  • [3] Cognition and diabetes: a lifespan perspective
    Biessels, Geert Jan
    Deary, Ian J.
    Ryan, Christopher M.
    [J]. LANCET NEUROLOGY, 2008, 7 (02) : 184 - 190
  • [4] The agony and ecstasy of "OMIC" technologies in drug development
    Bilello, JA
    [J]. CURRENT MOLECULAR MEDICINE, 2005, 5 (01) : 39 - 52
  • [5] Systematic discovery of multicomponent therapeutics
    Borisy, AA
    Elliott, PJ
    Hurst, NW
    Lee, MS
    Lehár, J
    Price, ER
    Serbedzija, G
    Zimmermann, GR
    Foley, MA
    Stockwell, BR
    Keith, CT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) : 7977 - 7982
  • [6] Buehler L.K., 2004, PHARMAGENOMICS, V4, P24
  • [7] PROGRESS IN TRADITIONAL CHINESE MEDICINE
    CHAN, K
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (06) : 182 - 187
  • [8] Molecular understanding and modern application of traditional medicines: Triumphs and trials
    Corson, Timothy W.
    Crews, Craig M.
    [J]. CELL, 2007, 130 (05) : 769 - 774
  • [9] Combination drugs, an emerging option for antibacterial therapy
    Cottarel, Guillaume
    Wierzbowski, Jamey
    [J]. TRENDS IN BIOTECHNOLOGY, 2007, 25 (12) : 547 - 555
  • [10] The efficiency of multi-target drugs: the network approach might help drug design
    Csermely, P
    Agoston, V
    Pongor, S
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (04) : 178 - 182